Monocyte to high-density lipoprotein cholesterol ratio as a marker of the presence and progression of diabetic kidney disease

Background Monocyte to high-density lipoprotein cholesterol ratio (MHR) is considered a novel marker of inflammation. However, whether MHR can predict the risk of diabetic kidney disease (DKD) remains uncertain. Our research aimed to investigate the relationship between MHR and DKD.Methods This was...

Full description

Saved in:
Bibliographic Details
Main Authors: Wentao Yang, Yuanlong Zhong, Pengying Zhou, Donghui Lu
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2438846
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841540134559809536
author Wentao Yang
Yuanlong Zhong
Pengying Zhou
Donghui Lu
author_facet Wentao Yang
Yuanlong Zhong
Pengying Zhou
Donghui Lu
author_sort Wentao Yang
collection DOAJ
description Background Monocyte to high-density lipoprotein cholesterol ratio (MHR) is considered a novel marker of inflammation. However, whether MHR can predict the risk of diabetic kidney disease (DKD) remains uncertain. Our research aimed to investigate the relationship between MHR and DKD.Methods This was a cross-sectional retrospective study of 159 participants with type 2 diabetes mellitus. MHR, urinary albumin-to-creatinine ratio (UACR) and other indexes were measured. According to UACR, participants were divided into normal group (UACR < 30 mg/g), moderately increased group (UACR 30-300 mg/g) and severely increased group (UACR > 300 mg/g). The association between MHR and DKD was analyzed.Results MHR was significantly elevated in severely increased albuminuria group (p = 0.029). The prevalence of DKD increased in parallel with the elevation in MHR (p = 0.009). MHR was positively related with DKD in univariate logistic regression analysis (ORs = 11.27, 95%CI 1.26-101.24, p = 0.031). Multivariable logistic regression analysis showed MHR significantly correlated with DKD (ORs = 6.20, 95%CI 1.49-25.84, p = 0.012). Each quartile elevation in MHR was associated with an increased risk of DKD (ORs = 1.90, 95%CI 1.19-3.01, p = 0.007). In subgroup analyses MHR was a risk factor for DKD, particularly in patients with HbA1c <8.0%.Conclusions Our findings suggest that MHR can be used as a marker for the presence and progression of DKD.
format Article
id doaj-art-90499c05186d43dba5949762b0c2a7e0
institution Kabale University
issn 0886-022X
1525-6049
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj-art-90499c05186d43dba5949762b0c2a7e02025-01-14T06:09:01ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492025-12-0147110.1080/0886022X.2024.2438846Monocyte to high-density lipoprotein cholesterol ratio as a marker of the presence and progression of diabetic kidney diseaseWentao Yang0Yuanlong Zhong1Pengying Zhou2Donghui Lu3Department of Endocrinology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, ChinaDepartment of Nephrology, Shenzhen Luohu People’s Hospital, The Third Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, ChinaHealth Management Center, Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, ChinaDepartment of Endocrinology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, ChinaBackground Monocyte to high-density lipoprotein cholesterol ratio (MHR) is considered a novel marker of inflammation. However, whether MHR can predict the risk of diabetic kidney disease (DKD) remains uncertain. Our research aimed to investigate the relationship between MHR and DKD.Methods This was a cross-sectional retrospective study of 159 participants with type 2 diabetes mellitus. MHR, urinary albumin-to-creatinine ratio (UACR) and other indexes were measured. According to UACR, participants were divided into normal group (UACR < 30 mg/g), moderately increased group (UACR 30-300 mg/g) and severely increased group (UACR > 300 mg/g). The association between MHR and DKD was analyzed.Results MHR was significantly elevated in severely increased albuminuria group (p = 0.029). The prevalence of DKD increased in parallel with the elevation in MHR (p = 0.009). MHR was positively related with DKD in univariate logistic regression analysis (ORs = 11.27, 95%CI 1.26-101.24, p = 0.031). Multivariable logistic regression analysis showed MHR significantly correlated with DKD (ORs = 6.20, 95%CI 1.49-25.84, p = 0.012). Each quartile elevation in MHR was associated with an increased risk of DKD (ORs = 1.90, 95%CI 1.19-3.01, p = 0.007). In subgroup analyses MHR was a risk factor for DKD, particularly in patients with HbA1c <8.0%.Conclusions Our findings suggest that MHR can be used as a marker for the presence and progression of DKD.https://www.tandfonline.com/doi/10.1080/0886022X.2024.2438846Diabetic kidney diseasediabetic nephropathymonocyte to high-density lipoprotein cholesterol ratioinflammationdiabetic complications
spellingShingle Wentao Yang
Yuanlong Zhong
Pengying Zhou
Donghui Lu
Monocyte to high-density lipoprotein cholesterol ratio as a marker of the presence and progression of diabetic kidney disease
Renal Failure
Diabetic kidney disease
diabetic nephropathy
monocyte to high-density lipoprotein cholesterol ratio
inflammation
diabetic complications
title Monocyte to high-density lipoprotein cholesterol ratio as a marker of the presence and progression of diabetic kidney disease
title_full Monocyte to high-density lipoprotein cholesterol ratio as a marker of the presence and progression of diabetic kidney disease
title_fullStr Monocyte to high-density lipoprotein cholesterol ratio as a marker of the presence and progression of diabetic kidney disease
title_full_unstemmed Monocyte to high-density lipoprotein cholesterol ratio as a marker of the presence and progression of diabetic kidney disease
title_short Monocyte to high-density lipoprotein cholesterol ratio as a marker of the presence and progression of diabetic kidney disease
title_sort monocyte to high density lipoprotein cholesterol ratio as a marker of the presence and progression of diabetic kidney disease
topic Diabetic kidney disease
diabetic nephropathy
monocyte to high-density lipoprotein cholesterol ratio
inflammation
diabetic complications
url https://www.tandfonline.com/doi/10.1080/0886022X.2024.2438846
work_keys_str_mv AT wentaoyang monocytetohighdensitylipoproteincholesterolratioasamarkerofthepresenceandprogressionofdiabetickidneydisease
AT yuanlongzhong monocytetohighdensitylipoproteincholesterolratioasamarkerofthepresenceandprogressionofdiabetickidneydisease
AT pengyingzhou monocytetohighdensitylipoproteincholesterolratioasamarkerofthepresenceandprogressionofdiabetickidneydisease
AT donghuilu monocytetohighdensitylipoproteincholesterolratioasamarkerofthepresenceandprogressionofdiabetickidneydisease